i-Base home
Search Menu
  • Home
  • HTB
  • 2006
  • February
  • 09

HTB

9 February 2006

Contents

Antiretrovirals

  • SMART study halted due to safety concerns with significantly more AIDS events in the treatment interruption arm
  • TMC114 (darunavir) new drug applications submitted to US and European regulatory agencies

Treatment access

  • Missing the target: a report on HIV/AIDS treatment access from the frontlines
  • New Clinton agreements to lower prices of HIV/AIDS rapid tests and second-line drugs in 50 countries
  • WHO adds seven antiretrovirals to list of prequalified HIV drugs
  • Ranbaxy launches two new ARVs in India
  • FDA tentative approvals: generic oral solutions of nevirapine and d4T
  • Amendment to WTO TRIPS agreement makes access to affordable medicines even more bleak: MSF expresses concern that patients the world-over will have to pay the price
  • WTO uses AIDS patients to cover up development round failure
  • HTB RSS

Early access

  • NICE guidelines on management of chronic pain: exercise but not opiods 9 April 2021
  • Bar opening in the US: 100 guests linked to at least 46 cases of COVID-19 9 April 2021
  • HTB: no. 4 – plus HIV and COVID-19 (1 April 2021) 1 April 2021
  • All early access reports

Current issues

  • April 2021
  • March 2021
  • February 2021
  • Back issues

Special report

  • HTB: no. 3 – plus HIV and COVID-19 (12 March 2021) 12 March 2021

More from HTB

  • Conference reports
  • Conference shortcuts
  • Articles by subject
  • PDFs
  • Subscribe
  • HTB homepage

Home

  • i-Base homepage

This website sets no cookies from us or anyone else.

Information on this website is provided by treatment advocates and offered as a guide only. Decisions about your treatment should always be taken in consultation with your doctor.

This site complies with the HONcode standard for trustworthy health information.

Verify here.

HIV i-BASE
About us - Contact - Cookies and privacy - Copyright waiver - Terms of use - Home
107 The Maltings, 169 Tower Bridge Road, London SE1 3LJ.
Tel + 44 (0) 208 616 2210. Email admin@i-base.org.uk
Registered charity no: 1081905. Company reg no: 3962064.

Search i-Base

Site navigation

Quick links
HIV positive
Advocate
Professional
Donate
Feedback
Advice and information
Q and A
Phoneline
Pocket info
Guides
HIV meds
Glossary
Research and conference reports
HTB
HTB South
Pipeline report
Publications and resources
Publications
Other resources
Translations
Slide sets
Order and subscribe
News and updates
News
Blogs
Advocates' network
UK-CAB
Training manual
i-Base
About us
Contact
Sitemap
Home
Find us on Facebook